RBC Capital Initiates Coverage On 10x Genomics with Sector Perform Rating, Announces Price Target of $70
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsInitiationPrice Target
RBC Capital analyst Dan Leonard initiates coverage on 10x Genomics (NASDAQ:TXG) with a Sector Perform rating and announces Price Target of $70.
RBC Capital analyst Dan Leonard initiates coverage on 10x Genomics (NASDAQ:TXG) with a Sector Perform rating and announces Price Target of $70.